SCHEMBL9541636

SCHEMBL9541636

CC(Cc1ccccc1N)(OC(N)=O)C(=O)NCCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 3/20 0.49
NPC1 O15118 7/20 0.45
RAB9A P51151 7/20 0.45
MAPT P10636 2/20 0.45
POLB P06746 1/20 0.45
OPRK1 P41145 2/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
ALOX12 P18054 1/20 0.44
CYP2C19 P33261 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
TAAR1 Q96RJ0 1/20 0.43
ESRRG P62508 2/20 0.41
MGLL Q99685 1/20 0.41
CCKBR P32239 1/20 0.40
CA12 O43570 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9538757 0.85 MTNR1A (0.50) MMP8NPC1RAB9AMAPTPOLB
SCHEMBL9539323 0.82 MMP8 (0.51) MMP8NPC1RAB9AMAPTPOLB
SCHEMBL9700657 0.81 MMP8 (0.46) MMP8NPC1RAB9AMAPTPOLB
SCHEMBL9538003 0.81 MMP8 (0.46) MMP8NPC1RAB9AMAPTPOLB
SCHEMBL9539180 0.80 MMP8 (0.44) MMP8NPC1RAB9AMAPTPOLB
SCHEMBL9540255 0.80 MMP8 (0.44) MMP8NPC1RAB9AMAPTPOLB
SCHEMBL9538098 0.80 MMP8 (0.44) MMP8NPC1RAB9AMAPTPOLB
SCHEMBL8486077 0.80 CCKBR (0.61) MAPTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL9699668 0.80 CCKBR (0.53) MMP8NPC1RAB9AMAPTPOLB
SCHEMBL9540074 0.79 RAB9A (0.51) MMP8NPC1RAB9AOPRK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993003721-A1 CHOLECYSTOKININ ANTAGONISTS USEFUL FOR TREATING DEPRESSION WARNER-LAMBERT COMPANY (US) 1993-03-04 WO disclosed